Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017:2017:8152610.
doi: 10.1155/2017/8152610. Epub 2017 Sep 13.

Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia

Affiliations
Case Reports

Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia

D Swan et al. Case Rep Hematol. 2017.

Abstract

We describe an unusual case of a biclonal nodal plasma cell dyscrasia, presenting with a vasculitic rash, end-organ damage, and cytopenias. Serum protein electrophoresis demonstrated a biclonal kappa-restricted paraprotein, with a negative skeletal survey and no bone marrow disease. Fluorodeoxyglucose-PET-CT (FDG-PET-CT) revealed nodal involvement, which was not appreciable clinically, and facilitated biopsy, confirming the diagnosis of a nodal plasmacytoma. Complete biochemical response and resolution of the vasculitic rash were achieved with bortezomib-based therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a, b, c) Diagnostic axial FDG-PET images illustrate FDG-avid axillary, mediastinal, and cervical nodes, respectively. (c, d, f) Posttreatment axial PDG-PET images illustrate no FDG-avid evidence of residual disease at cervical, mediastinal, and axillary nodes, respectively.
Figure 2
Figure 2
Left axillary lymph node biopsy. (a) Haematoxylin and eosin stain at ×40. (b) CD138 stain at ×40, strongly positive. (c) Kappa stain at ×40, strongly positive. (d) Lambda stain at ×40, negative demonstrating kappa light chain restriction.

Similar articles

References

    1. Pratt G., Jenner M., Owen R., et al. Updates to the guidelines for the diagnosis and management of multiple myeloma. British Journal of Haematology. 2014;167(1):131–133. doi: 10.1111/bjh.12926. - DOI - PubMed
    1. Loricera J., Calvo-Río V., Ortiz-Sanjuán F., et al. The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features. Medicine (United States) 2013;92(6):331–343. doi: 10.1097/MD.0000000000000009. - DOI - PMC - PubMed
    1. Kyle R. A., Robinson R. A., Katzmann J. A. The clinical aspects of biclonal gammopathies. Review of 57 cases. The American Journal of Medicine. 1981;71(6):999–1008. doi: 10.1016/0002-9343(81)90326-0. - DOI - PubMed
    1. Mullikin T. C., Rajkumar S. V., Dispenzieri A., et al. Clinical characteristics and outcomes in biclonal gammopathies. American Journal of Hematology. 2016;91(5):473–475. doi: 10.1002/ajh.24319. - DOI - PMC - PubMed
    1. Chen Z. W., Kotsikogianni I., Raval J. S., Roth C. G., Rollins-Raval M. A. Biclonal IgD and IgM plasma cell myeloma: a report of two cases and a literature review. Case Reports in Hematology. 2013;2013:1–5. doi: 10.1155/2013/293150.293150 - DOI - PMC - PubMed

Publication types

LinkOut - more resources